menu
Your Cart

ITT4751

ITT4751
  • Catalog: ITT4751
  • Gene/Protein: TRPS1
  • Product Description: Immunotag™ TRPS1 Polyclonal Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ TRPS1 Polyclonal Antibody
Antibody Specification
Datasheet
Target Protein TRPS1
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application IHC-p,WB,ELISA
Recommended Dilution WB 1:500-2000 Immunohistochemistry: 1/100 - 1/300. ELISA: 1/5000. Not yet tested in other applications.
Concentration 1 mg/ml
Reactive Species Human,Mouse
Host Species Rabbit
Immunogen The antiserum was produced against synthesized peptide derived from human TRPS1. AA range:121-170
Specificity TRPS1 Polyclonal Antibody detects endogenous levels of TRPS1 protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
Form Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Gene Name TRPS1
Accession No. Q9UHF7 Q925H1
Alternate Names TRPS1; Zinc finger transcription factor Trps1; Tricho-rhino-phalangeal syndrome type I protein; Zinc finger protein GC79
Description transcriptional repressor GATA binding 1(TRPS1) Homo sapiens This gene encodes a transcription factor that represses GATA-regulated genes and binds to a dynein light chain protein. Binding of the encoded protein to the dynein light chain protein affects binding to GATA consensus sequences and suppresses its transcriptional activity. Defects in this gene are a cause of tricho-rhino-phalangeal syndrome (TRPS) types I-III. [provided by RefSeq, Jul 2008],
Protein Expression Embryo,Epithelium,Prostate,
Subcellular Localization nuclear chromatin,nucleus,nucleoplasm,transcription factor complex,
Protein Function disease:A chromosomal aberration involving TRPS1 is a cause of tricho-rhino-phalangeal syndrome type II (TRPS2) [MIM:150230]. TRPS2 is a contiguous gene syndrome due to deletions in chromosome 8q24.1 and resulting in the loss of functional copies of TRPS1 and EXT1.,disease:Defects in TRPS1 are the cause of tricho-rhino-phalangeal syndrome type I (TRPS1) [MIM:190350]. TRPS1 is an autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type III. Typical features include sparse scalp hair, a bulbous tip of the nose, protruding ears, a long flat philtrum and a thin upper vermilion border. Skeletal defects include cone-shaped epiphyses at the phalanges, hip malformations and short stature.,disease:Defects in TRPS1 are the cause of tricho-rhino-phalangeal syndrome type III (TRPS3) [MIM:190351]. TRPS3 is an autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type I. In TRPS3 a more severe brachydactyly and growth retardation are observed.,function:Transcriptional repressor. May act to restrict expression of GATA-regulated genes at selected sites and stages in vertebrate development. Might be involved in prostate cancer apoptosis.,similarity:Contains 1 GATA-type zinc finger.,similarity:Contains 7 C2H2-type zinc fingers.,subunit:Binds specifically to GATA sequences.,tissue specificity:Ubiquitously expressed in the adult. Found in fetal brain, lung, kidney, liver, spleen and thymus. More highly expressed in androgen-dependent than in androgen-independent prostate cancer cells.,
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US